Zou B - Search Results

1

Impact of nab-paclitaxel plus PD-1/PD-L1 inhibitor on chemorefractory relapsed small-cell lung cancer.

Mu F, Fan B, Li H, Qin W, Wang C, Zou B, Wang L. Mu F, et al. Among authors: zou b. Future Oncol. 2023 Jun;19(19):1367-1378. doi: 10.2217/fon-2023-0076. Epub 2023 Apr 28. Future Oncol. 2023. PMID: 37114967

2

Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC.

Guo M, Li W, Li B, Zou B, Wang S, Meng X, Sun X, Yu J, Wang L. Guo M, et al. Among authors: zou b. Int Immunopharmacol. 2019 Jul;72:395-401. doi: 10.1016/j.intimp.2019.04.032. Epub 2019 Apr 24. Int Immunopharmacol. 2019. PMID: 31030095

3

Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases.

Li B, Wang R, Zhang T, Sun X, Jiang C, Li W, Zou B, Xie P, Meng X, Sun X, Wang L, Yu J. Li B, et al. Among authors: zou b. Sci Rep. 2020 Jul 9;10(1):11259. doi: 10.1038/s41598-020-68160-6. Sci Rep. 2020. PMID: 32647289 Free PMC article.

4

Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer.

Li B, Jiang C, Wang R, Zou B, Xie P, Li W, Sun X, Yu J, Wang L. Li B, et al. Among authors: zou b. Onco Targets Ther. 2020 Sep 11;13:9043-9057. doi: 10.2147/OTT.S262084. eCollection 2020. Onco Targets Ther. 2020. PMID: 32982294 Free PMC article.

5

Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients.

Guo M, Li W, Li B, Zou B, Wang S, Fan B, Sun X, Wang L. Guo M, et al. Among authors: zou b. Front Oncol. 2020 Oct 14;10:571380. doi: 10.3389/fonc.2020.571380. eCollection 2020. Front Oncol. 2020. PMID: 33154945 Free PMC article.

6

Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy.

Li X, Zhang D, Li B, Zou B, Wang S, Fan B, Li W, Yu J, Wang L. Li X, et al. Among authors: zou b. Lung Cancer. 2021 Jan;151:39-43. doi: 10.1016/j.lungcan.2020.12.002. Epub 2020 Dec 3. Lung Cancer. 2021. PMID: 33296806

7

Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review.

Li B, Jiang C, Pang L, Zou B, Ding M, Sun X, Yu J, Wang L. Li B, et al. Among authors: zou b. Front Immunol. 2021 Mar 30;12:627197. doi: 10.3389/fimmu.2021.627197. eCollection 2021. Front Immunol. 2021. PMID: 33859637 Free PMC article.

8

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.

Zhao Q, Li B, Xu Y, Wang S, Zou B, Yu J, Wang L. Zhao Q, et al. Among authors: zou b. Cancer Med. 2021 Sep;10(18):6291-6303. doi: 10.1002/cam4.4171. Epub 2021 Aug 13. Cancer Med. 2021. PMID: 34390218 Free PMC article.

9

XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy.

Li X, Zou B, Wang S, Wang L, Yu J. Li X, et al. Among authors: zou b. J Transl Med. 2021 Oct 9;19(1):421. doi: 10.1186/s12967-021-03098-5. J Transl Med. 2021. PMID: 34627293 Free PMC article. No abstract available.

10

Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer.

Xu Y, Cui H, Dong T, Zou B, Fan B, Li W, Wang S, Sun X, Yu J, Wang L. Xu Y, et al. Among authors: zou b. Front Oncol. 2021 Nov 23;11:688706. doi: 10.3389/fonc.2021.688706. eCollection 2021. Front Oncol. 2021. PMID: 34888228 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,102 results

Search Page

Filters